NorthRock Partners LLC Grows Stock Position in Humana Inc. $HUM

Key Points

• NorthRock Partners LLC significantly increased its stake in Humana Inc. by 199.6% during the second quarter, now owning 2,394 shares valued at $585,000.
• Humana's latest quarterly earnings showed an EPS of $6.27, which missed analysts' expectations, but revenue increased by 9.6% year-over-year, totaling $32.39 billion.
• The company announced a quarterly dividend of $0.885 per share, equating to an annualized dividend of $3.54 and a yield of 1.3%.

NorthRock Partners LLC increased its stake in Humana Inc. (NYSE:HUM - Free Report) by 199.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,394 shares of the insurance provider's stock after buying an additional 1,595 shares during the quarter. NorthRock Partners LLC's holdings in Humana were worth $585,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Cary Street Partners Investment Advisory LLC grew its stake in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after buying an additional 46 shares during the last quarter. Applied Finance Capital Management LLC raised its stake in Humana by 1.7% in the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock valued at $779,000 after buying an additional 48 shares during the last quarter. Blue Trust Inc. boosted its holdings in Humana by 3.6% in the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider's stock worth $334,000 after acquiring an additional 48 shares in the last quarter. Achmea Investment Management B.V. grew its stake in shares of Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after acquiring an additional 49 shares during the last quarter. Finally, Beech Hill Advisors Inc. increased its holdings in shares of Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock valued at $229,000 after acquiring an additional 50 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Humana Stock Up 0.3%

Shares of HUM stock opened at $262.29 on Thursday. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35. The stock has a market cap of $31.55 billion, a P/E ratio of 20.13, a P/E/G ratio of 1.53 and a beta of 0.42. The stock has a 50 day moving average of $280.15 and a 200 day moving average of $258.14. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the business earned $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana's dividend payout ratio is 27.17%.

Wall Street Analyst Weigh In

A number of research firms recently commented on HUM. Barclays lowered their target price on shares of Humana from $315.00 to $245.00 and set an "equal weight" rating for the company in a research note on Friday, October 3rd. The Goldman Sachs Group began coverage on shares of Humana in a research note on Tuesday. They set a "sell" rating and a $235.00 price objective for the company. Piper Sandler cut their target price on Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Bank of America raised their target price on Humana from $280.00 to $300.00 and gave the stock a "neutral" rating in a research note on Friday, October 10th. Finally, Truist Financial set a $300.00 price target on Humana in a research note on Tuesday. Eight investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, Humana currently has a consensus rating of "Hold" and an average target price of $297.58.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.